Products
Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.
NeuroLens®
Neuron Cell-Death Test
RNA Clarity™
RNA Vaccine QC
MethylMap™
Native-Read Methylation Sequencing
Older woman discussing a clinical diagnosis with a female doctor who is reviewing a tablet in a medical office.
Services
Services
End-to-end sequencing services supporting genomic, epigenomic, and transcriptomic analysis, from experimental design and assay development to bioinformatics, interpretation, and data delivery.
Applications
Applications
Explore how our products and services help solve difficult biological and genomic problems, from liquid biopsy signals to complex regions and emerging biomarker development.
Hard-to-Sequence Genes & Complex Regions
Liquid Biopsy cfDNA Analysis
Targeted Panel Development
Close-up of overlapping teal and green curved panels with light reflections and a smooth gradient.
Company
Company
Building the future of precision diagnostics through sequencing innovation, scientific rigor, and collaborative partnerships.
About Us
Development & Validation
Team
Building with a black facade featuring white 3D letters spelling 'RENEW' and a geometric logo.
Resources
Contact
  • Applications
  • Applications
    Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging, cancer, and neurodegeneration research.
    Telomeres, the protective caps at the end of our chromosomes, sit at the intersection of aging.
    Research & Translation
    Biopharma Research
    Clinical Development
    Abstract digital pattern of glowing rectangular bars in green and blue on a dark background.
Neurodegeneration
January 29, 2025

Methylation Sequencing for Early Alzheimer’s Detection

close up of viles in a plate for sequencing
BYU Life Sciences team leads a validation study of a blood test for early Alzheimer’s detection in collaboration with Kansas University.

BYU researchers are collaborating with the University of Kansas Alzheimer’s Disease Research Center (KU AADRC) to pave the way for early detection through a validation study of a blood test designed to detect Alzheimer’s disease neurodegeneration in its infancy. If successful, this test could support Alzheimer’s research and earlier detection, monitor disease progression, and lay the foundation for new diagnostic tools and treatments.

View full article on BYU College of Life Sciences

‍

Additional Resources
Industry Trends
August 28, 2025
Transcripts, Uncut: The Value Of Long-Read cDNA Sequencing in Transcriptomic Discovery
Research Highlights
August 8, 2024
NGS Liquid Biopsy Technologies: Transforming Clinical Diagnostics
Publication
October 31, 2023
Neuron-Derived cfDNA Detection by Methylation Sequencing
Discover More
Join For Updates
Success! Thank you for joining our newsletter.
Oops! Something went wrong while submitting the form.
© 2026 Renew Biotechnologies | All Rights Reserved
CAP 7654476 | CLIA 46D2309073